Found: 207
Select item for more details and to access through your institution.
Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 136, doi. 10.3390/vaccines10020136
- By:
- Publication type:
- Article
The Course of Anti-HBc Antibodies over Time in Immunocompromised Hosts.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 137, doi. 10.3390/vaccines10020137
- By:
- Publication type:
- Article
Plant-Based Vaccines in Combat against Coronavirus Diseases.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 138, doi. 10.3390/vaccines10020138
- By:
- Publication type:
- Article
Establishment of an Artificial Neural Network Model Using Immune-Infiltration Related Factors for Endometrial Receptivity Assessment.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 139, doi. 10.3390/vaccines10020139
- By:
- Publication type:
- Article
The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 140, doi. 10.3390/vaccines10020140
- By:
- Publication type:
- Article
Reduced Titers of Circulating Anti-SARS-CoV-2 Antibodies and Risk of COVID-19 Infection in Healthcare Workers during the Nine Months after Immunization with the BNT162b2 mRNA Vaccine.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 141, doi. 10.3390/vaccines10020141
- By:
- Publication type:
- Article
A Knowledge, Attitude, and Perception Study on Flu and COVID-19 Vaccination during the COVID-19 Pandemic: Multicentric Italian Survey Insights.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 142, doi. 10.3390/vaccines10020142
- By:
- Publication type:
- Article
Training Physicians in Motivational Communication to Address Influenza Vaccine Hesitation: A Proof-of-Concept Study.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 143, doi. 10.3390/vaccines10020143
- By:
- Publication type:
- Article
microRNA, a Subtle Indicator of Human Cytomegalovirus against Host Immune Cells.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 144, doi. 10.3390/vaccines10020144
- By:
- Publication type:
- Article
Predictors of Survival after Vaccination in a Pneumonic Plague Model.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 145, doi. 10.3390/vaccines10020145
- By:
- Publication type:
- Article
Intention to Receive the COVID-19 Vaccine Booster Dose in a University Community in Italy.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 146, doi. 10.3390/vaccines10020146
- By:
- Publication type:
- Article
Declared Intention (Not) to Be Vaccinated against COVID-19, and Actual Behavior—The Longitudinal Study in the Polish Sample.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 147, doi. 10.3390/vaccines10020147
- By:
- Publication type:
- Article
The Highly Productive Thermothelomyces heterothallica C1 Expression System as a Host for Rapid Development of Influenza Vaccines.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 148, doi. 10.3390/vaccines10020148
- By:
- Publication type:
- Article
Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus Vaccines.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 149, doi. 10.3390/vaccines10020149
- By:
- Publication type:
- Article
Increasing Uptake of Maternal Pertussis Vaccinations through Funded Administration in Community Pharmacies.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 150, doi. 10.3390/vaccines10020150
- By:
- Publication type:
- Article
Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 151, doi. 10.3390/vaccines10020151
- By:
- Publication type:
- Article
Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against Toxoplasma gondii Challenge Infection.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 152, doi. 10.3390/vaccines10020152
- By:
- Publication type:
- Article
Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 153, doi. 10.3390/vaccines10020153
- By:
- Publication type:
- Article
Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 154, doi. 10.3390/vaccines10020154
- By:
- Publication type:
- Article
Targeting Secreted Protease/Anti-Protease Balance as a Vaccine Strategy against the Helminth Fasciola hepatica.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 155, doi. 10.3390/vaccines10020155
- By:
- Publication type:
- Article
Parents' Willingness to Vaccinate Children against COVID-19 in Saudi Arabia: A Cross-Sectional Study.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 156, doi. 10.3390/vaccines10020156
- By:
- Publication type:
- Article
Effectiveness of Vaccination against SARS-CoV-2 Infection in the Pre-Delta Era: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 157, doi. 10.3390/vaccines10020157
- By:
- Publication type:
- Article
The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 158, doi. 10.3390/vaccines10020158
- By:
- Publication type:
- Article
Vaccine Coverage against Influenza and SARS-CoV-2 in Health Sciences Students during COVID-19 Pandemic in Spain.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 159, doi. 10.3390/vaccines10020159
- By:
- Publication type:
- Article
Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 160, doi. 10.3390/vaccines10020160
- By:
- Publication type:
- Article
Vaccine Hesitancy and Anti-Vaccination Attitudes during the Start of COVID-19 Vaccination Program: A Content Analysis on Twitter Data.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 161, doi. 10.3390/vaccines10020161
- By:
- Publication type:
- Article
Selection of an Optimal Recombinant Egyptian H9N2 Avian Influenza Vaccine Strain for Poultry with High Antigenicity and Safety.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 162, doi. 10.3390/vaccines10020162
- By:
- Publication type:
- Article
Active Humoral Response Reverts Tumorigenicity through Disruption of Key Signaling Pathway.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 163, doi. 10.3390/vaccines10020163
- By:
- Publication type:
- Article
COVID-19 Vaccination in Cancer Patients Older Than 70 Years Undergoing Active Treatment. Seroconversion Rate and Safety.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 164, doi. 10.3390/vaccines10020164
- By:
- Publication type:
- Article
Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 165, doi. 10.3390/vaccines10020165
- By:
- Publication type:
- Article
COVID-19 Infection in Pregnancy: Obstetrical Risk Factors and Neonatal Outcomes—A Monocentric, Single-Cohort Study.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 166, doi. 10.3390/vaccines10020166
- By:
- Publication type:
- Article
Immunization of Nile Tilapia (Oreochromis niloticus) Broodstock with Tilapia Lake Virus (TiLV) Inactivated Vaccines Elicits Protective Antibody and Passive Maternal Antibody Transfer.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 167, doi. 10.3390/vaccines10020167
- By:
- Publication type:
- Article
National COVID-19 Vaccine Program and Parent's Perception to Vaccinate Their Children: A Cross-Sectional Study.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 168, doi. 10.3390/vaccines10020168
- By:
- Publication type:
- Article
Clinical Profiles and CMR Findings of Young Adults and Pediatrics with Acute Myocarditis Following mRNA COVID-19 Vaccination: A Case Series.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 169, doi. 10.3390/vaccines10020169
- By:
- Publication type:
- Article
Engineering His-Tagged Senecavirus A for One-Step Purification of Viral Antigens.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 170, doi. 10.3390/vaccines10020170
- By:
- Publication type:
- Article
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 171, doi. 10.3390/vaccines10020171
- By:
- Publication type:
- Article
Role of Physiology, Immunity, Microbiota, and Infectious Diseases in the Gut Health of Poultry.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 172, doi. 10.3390/vaccines10020172
- By:
- Publication type:
- Article
Immunization with GP1 but Not Core-like Particles Displaying Isolated Receptor-Binding Epitopes Elicits Virus-Neutralizing Antibodies against Junín Virus.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 173, doi. 10.3390/vaccines10020173
- By:
- Publication type:
- Article
Determinants of the Development of SARS-CoV-2 Anti-Spike Immune-Response after Vaccination among Healthcare Workers in Egypt.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 174, doi. 10.3390/vaccines10020174
- By:
- Publication type:
- Article
Tipping the Fencesitters—The Impact of a Minimal Intervention Enhanced with Biological Facts on Swiss Student Teachers' Perception of HPV Vaccination Safety.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 175, doi. 10.3390/vaccines10020175
- By:
- Publication type:
- Article
Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 176, doi. 10.3390/vaccines10020176
- By:
- Publication type:
- Article
Waning of Anti-SARS-CoV-2 Spike Antibody Levels 100 to 200 Days after the Second Dose of the BNT162b2 Vaccine.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 177, doi. 10.3390/vaccines10020177
- By:
- Publication type:
- Article
Comparison of Social Inequality in Human Papillomavirus (HPV) Vaccination among Teenagers with Parental Reports and Healthcare Providers' Records in the 2019 National Immunization Survey-Teen.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 178, doi. 10.3390/vaccines10020178
- By:
- Publication type:
- Article
Parents' and Guardians' Willingness to Vaccinate Their Children against COVID-19: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 179, doi. 10.3390/vaccines10020179
- By:
- Publication type:
- Article
Low Neutralizing Antibody Titers against the Mu Variant of SARS-CoV-2 in 31 BNT162b2 Vaccinated Individuals in Colombia.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 180, doi. 10.3390/vaccines10020180
- By:
- Publication type:
- Article
Persistence of Immunity in Adults after 1, 5 and 10 Years with Recombinant Hepatitis B Vaccine in Beijing in 2010–2020.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 181, doi. 10.3390/vaccines10020181
- By:
- Publication type:
- Article
Cellular Immune Response after Vaccination in Patients with Cancer—Review on Past and Present Experiences.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 182, doi. 10.3390/vaccines10020182
- By:
- Publication type:
- Article
New Insight in Vaccination and Public Health: A Commentary from Special Issue Editors.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 183, doi. 10.3390/vaccines10020183
- By:
- Publication type:
- Article
Evaluation of HSV-2 gE Binding to IgG-Fc and Application for Vaccine Development.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 184, doi. 10.3390/vaccines10020184
- By:
- Publication type:
- Article
Seroprevalence of Measles Antibodies in the Population of the Olomouc Region, Czech Republic—Comparison of the Results of Four Laboratories.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 185, doi. 10.3390/vaccines10020185
- By:
- Publication type:
- Article